160 related articles for article (PubMed ID: 16038266)
1. [Effect of calmodulin antagonist EBB on invasion of human fibrosarcoma cell HT1080].
Pan B; Zhou Y; Qi J; Xiong DS; Liu JW; Qi SL; Cheng YH; Yang CZ; Zhu HF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):311-4. PubMed ID: 16038266
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
[TBL] [Abstract][Full Text] [Related]
5. 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
Park BC; Thapa D; Lee YS; Kwak MK; Lee ES; Choi HG; Yong CS; Kim JA
Eur J Pharmacol; 2007 Jul; 567(3):193-7. PubMed ID: 17507007
[TBL] [Abstract][Full Text] [Related]
6. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Zhang J; Wang B
Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
[TBL] [Abstract][Full Text] [Related]
8. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells.
Pan B; Zhao MH; Chen Z; Lu L; Wang Y; Shi DW; Han PZ
Endocr Relat Cancer; 2007 Dec; 14(4):1063-71. PubMed ID: 18045957
[TBL] [Abstract][Full Text] [Related]
10. [Protein tyrosine kinase inhibitor genistein suppresses in vitro invasion of HT1080 human fibrosarcoma cells].
Yan C; Han R
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):171-4. PubMed ID: 11776827
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y
Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
Yamashita Y; Ishiguro Y; Sano D; Kimura M; Fujita K; Yoshida T; Horiuchi C; Taguchi T; Matsuda H; Mikami Y; Tsukuda M
Auris Nasus Larynx; 2007 Dec; 34(4):487-91. PubMed ID: 17337140
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
[TBL] [Abstract][Full Text] [Related]
15. [Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].
Wang J; Liu YS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):647-50. PubMed ID: 16114548
[TBL] [Abstract][Full Text] [Related]
16. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
17. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
18. [The inhibitory effect of recombinant polypeptide CH50 of fibronectin on invasion and angiogenesis of tumors].
Yu ZR; Zhang GM; Li D; Liu Y; Geng H; Xiao H; Wu FH; Feng ZH
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):815-9. PubMed ID: 17416001
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):662-5. PubMed ID: 17274370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]